//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Urology Resident & Doctoral Student in Clinical Epidemiology at the University of Toronto | Alum of McGill Medicine & Harvard Chan School of Public Health | he/him
David-Dan Nguyen








Loading...
In @jama.com, we identify a blind spot for FDA-listed AI/ML devices 🤖🔍 Over 90% have no reported manufacturer payments to clinicians or hospitals in Open Payments (US disclosure database) As AI enters care, transparency can’t lag jamanetwork.com/journals/jam...
8mo
This study examines the extent and nature of payments made to health care professionals and teaching hospitals by manufacturers of FDA-authorized AI- and machine learning–enabled devices.
jamanetwork.com
Payments by AI- and Machine Learning–Enabled Medical Device Manufacturers
David-Dan Nguyen
We're thrilled to announce the 2025–26 Schwartz Reisman Institute Graduate Fellows! 🎉 15 outstanding PhD students from @uoft.bsky.social will join our interdisciplinary community exploring how advanced technologies can better serve society. Meet them 👉 srinstitute.utoronto.ca/news/schswar...
Jun 9, 2025
srinstitute.utoronto.ca
The Schwartz Reisman Institute for Technology and Society is proud to announce the appointment of fifteen new graduate fellows from across the University of Toronto.
Schwartz Reisman Institute announces 2025–26 graduate fellows — Schwartz Reisman Institute
Schwartz Reisman Institute for Technology and Society
Updated review finds PSA screening linked to lower prostate cancer mortality over the long term. bit.ly/3QMI6nO
Is it time for Canada to revisit its approach to prostate cancer screening? www.sciencedirect.com/science/arti...
2d